Skip to content
10-Q

Quarterly Report

Cellcyte Genetics Corp.

0001056520-12-000210

← back to feed
Filed
May 15, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Mar 31, 2012 82.33M sh
Operating Cash Flow Q1 2012 · Mar 31, 2012 −$6M
Operating Cash Flow Q1 2012 · Mar 31, 2011 −$41.91K
Long Term Debt Q1 2012 · Mar 31, 2012 $281.27K
Long Term Debt Q1 2012 · Dec 31, 2011 $196.83K
Current Liabilities Q1 2012 · Mar 31, 2012 $1.1M
Current Liabilities Q1 2012 · Dec 31, 2011 $1.08M
Current Assets Q1 2012 · Mar 31, 2012 $76.3K
Current Assets Q1 2012 · Dec 31, 2011 $8.68K
Total Assets Q1 2012 · Mar 31, 2012 $103.11K
Total Assets Q1 2012 · Dec 31, 2011 $39.41K
Sga Expense Q1 2012 · Mar 31, 2012 $2.54M
Sga Expense Q1 2012 · Mar 31, 2011 $16.45K
Rd Expense Q1 2012 · Mar 31, 2012 $1.3M